USBC, Inc.: Form 10-Q for the period ended Jun 30, 2012
Filed with the SEC on Aug 10, 2012 and accepted by EDGAR at Aug 10, 2012, 16:08 ET.
Management's discussion and analysis
As filed, 14,758 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Forward-looking statements in this report reflect the good-faith judgment of our management and the statements are based on facts and factors as we currently know them. Forward-looking statements are subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, but are not limited to, those discussed below as well as those discussed elsewhere in this report (including in Part II, Item 1A (Risk Factors)). Readers are urged not to place undue reliance on these forward-looking statements because they speak only as of the date of this report. We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this report.
We were incorporated under the laws of the State of Nevada on October 8, 1998 with authorized common stock of 200,000,000 shares at $0.001 par value. On September 13, 2002, 50,000,000 shares of preferred stock with a par value of $0.001 were authorized by the shareholders. There are no preferred shares issued and the terms have not been determined. Our executive offices are located in Seattle, Washington.
We develop low-cost, high speed, light-based security and quality control solutions for use in homeland security, anti-counterfeiting, forgery/fraud prevention, brand protection, process control applications, and diagnostics. Our patented and patent-pending technology uses controlled illumination with specific bands of light, to establish a unique spectral signature for both individual and classes of items. When matched against existing databases, these spectral signatures allow precise identification and authentication or diagnostics of any item or substance. This breakthrough optical sensing and data capture technology is called Spectral Pattern Matching (SPM). SPM technology lends itself to flexible form factors and can be miniaturized, and is easily integrated into a variety of hand-held or fixed mount configurations, and can be a stand-alone device or combined in the same package as a bar-code or biometric scanner.
On September 6, 2011, the Company announced that it was issued US Patent No. 7,996,173, entitled “Method, Apparatus and Article to Facilitate Distributed Evaluation of Objects Using Electromagnetic Energy,” by the United States Office of Patents and Trademarks.
On January 19, 2012, the Company announced that it was issued US Patent No. 8,081,304, entitled “Method, Apparatus and Article to Facilitate Evaluation of Objects Using Electromagnetic Energy” by the United States Office of Patents and Trademarks.
On March 20, 2012, the Company announced that it was issued US Patent No. 8,076,630, entitled “System and Method of Evaluating an Object Using Electromagnetic Energy” by the United States Office of Patents and Trademarks.
We are pursuing an aggressive patent strategy to expand our unique intellectual property in the United States and Japan.
JOINT DEVELOPMENT AGREEMENT WITH SUMITOMO PRECISION PRODUCTS CO., LTD.
On May 31, 2012, the Company entered into a Joint Research and Product Development Agreement (the “Joint Development Agreement”) with Sumitomo Precision Products Co., Ltd. (“SPP”), a publicly-listed Japanese corporation for the commercialization of Visualant’s SPM technology. A copy of the Joint Development Agreement was filed by the Company with its Form 8-K filed June 4, 2012.
SPP invested $2,250,000 in exchange for 17,307,693 shares of restricted common shares priced at $0.13 per share that was funded on June 21, 2012. SPP also paid the Company an initial payment of $1 million in accordance with the terms of the License Agreement filed by the Company with its Form 8-K filed June 4, 2012. A running royalty for the license granted under the License Agreement will be negotiated at the completion of the Joint Development Agreement.
The parties have been working together since 2011, developing and testing the SPM products, analyzing the market potential for the SPM technology and developing a product plan.
SPP is publicly traded on the Tokyo and Osaka Stock Exchanges and has operations in Japan, United States, China, United Kingdom, Canada and other parts of the world. Additional details are available at http://www.spp.co.jp/English/index2-e.html.
THE COMPANY’S COMMON STOCK
Our common stock trades on the OTCBB Exchange under the symbol “VSUL.OB.”
KEY MARKET PRIORITIES
Currently, our key market priorities are, among other things, to:
Commercialize the SPM technology, including the following:
Complete work under the Joint Development Agreement with SPP.
Accelerate business development in the United States and Japan.
Develop license and royalty producing opportunities and partners, including major companies in the US, Europe and Asia.
Develop our patent portfolio by continually extending the reach and application of our intellectual property.
Launch an application product utilizing smartphone technology.
Improve our operations, including the following:
Improve the profitability of TransTech and the company.
Enhance our investor relation activities.
PRIMARY RISKS AND UNCERTAINTIES
We are exposed to various risks related to our need for additional financing, the sale of significant numbers of our shares, a volatile market price for our common stock and our merger and acquisition activities. These risks and uncertainties are discussed in more detail below in Part II, Item 1A.
RESULTS OF OPERATIONS
The following table presents certain consolidated statement of operations information and presentation of that data as a percentage of change from period-to-period.
THREE MONTHS ENDED JUNE 30, 2012 COMPARED TO THE THREE MONTHS ENDED JUNE 30, 2011
(dollars in thousands)
| Three Months Ended June 30, 2012 | 2011 | $ Variance | % Variance | |
|---|---|---|---|---|
| Revenue | $1,814 | $2,103 | $(289) | -13.7% |
| Cost of sales | 1,458 | 1,679 | (221) | 13.2% |
| Gross profit | 356 | 424 | (68) | -16.0% |
| Research and development expenses | 23 | 83 | (60) | 72.3% |
| Selling, general and administrative expenses | 1,076 | 1,248 | (172) | 13.8% |
| Operating loss | (743) | (907) | 164 | 18.1% |
| Other income (expense): | ||||
| Interest expense | (12) | (48) | 36 | 75.0% |
| Other income | 7 | 6 | 1 | 16.7% |
| Total other expense | (5) | (42) | 37 | 88.1% |
| Loss before income taxes | (748) | (949) | 201 | 21.2% |
| Income taxes - current benefit | (10) | (1) | (9) | -900.0% |
| Net loss | (738) | (948) | 210 | 22.2% |
| Non-controlling interest | (1) | 1 | (2) | -200.0% |
| Net loss attributable to Visualant, Inc. common shareholders | $(737) | $(949) | $212 | 22.3% |
17
SALES
Net revenue for the three months ended June 30, 2012 decreased $289,000 to $1,814,000 as compared to $2,103,000 for the three months ended June 30, 2011. The reduction was due to lower sales at TransTech.
COST OF SALES
Cost of sales for the three months ended June 30, 2012 decreased $221,000 to $1,458,000 as compared to $1,679,000 for the three months ended June 30, 2012. The reduction was due to lower sales at TransTech.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSE
Selling, general and administrative expenses for the three months ended June 30, 2012 decreased $172,000 to $1,076,000 as compared to $1,248,000 for the three months ended June 30, 2011. The decrease was due to reduced expenses. We recorded $195,000 in expenses related to the SPP transactions during the three month ended June 30, 2012.
During the three months ended June 30, 2012, we recorded non-cash expenses of $137,000.
The selling, general and administrative expenses consisted primarily of research and development expenses, employee and independent contractor expenses, overhead, equipment and depreciation, amortization of identifiable intangible assets and intellectual property, professional and consulting fees, investor relation, legal, patent, stock option and other general and administrative costs.
OTHER INCOME/EXPENSE
Other expense for the three months ended June 30, 2012 was $5,000 as compared to other expense of $42,000 for the three months ended June 30, 2011. The expenses for the three months ended June 30, 2012 included $12,000 for interest expense, offset by $7,000 in other income. The other expense for the three months ended June 30, 2011 included interest expense of $48,000, offset by other income of $6,000.
NET LOSS
Net loss for the three months ended June 30, 2012 was $737,000 as compared to a net loss of $949,000 for the three months ended June 30, 2011 for the reasons discussed above. The net loss included non-cash expenses of $137,000.
NINE MONTHS ENDED JUNE 30, 2012 COMPARED TO THE NINE MONTHS ENDED JUNE 30, 2011
(dollars in thousands)
| Nine Months Ended June 30, 2012 | 2011 | $ Variance | % Variance | |
|---|---|---|---|---|
| Revenue | $5,526 | $7,037 | $(1,511) | -21.5% |
| Cost of sales | 4,513 | 5,855 | (1,342) | 22.9% |
| Gross profit | 1,013 | 1,182 | (169) | -14.3% |
| Research and development expenses | 99 | 95 | 4 | -4.2% |
| Selling, general and administrative expenses | 2,754 | 2,726 | 28 | -1.0% |
| Operating loss | (1,840) | (1,639) | (201) | -12.3% |
| Other income (expense): | ||||
| Interest expense | (129) | (149) | 20 | 13.4% |
| Other income | 20 | 61 | (41) | -67.2% |
| Total other expense | (109) | (88) | (21) | -23.9% |
| Loss before income taxes | (1,949) | (1,727) | (222) | -12.9% |
| Income taxes - current benefit | (24) | (7) | (17) | -242.9% |
| Net loss | (1,925) | (1,720) | (205) | -11.9% |
| Non-controlling interest | 3 | 9 | (6) | -66.7% |
| Net loss attributable to Visualant, Inc. common shareholders | $(1,928) | $(1,729) | $(199) | -11.5% |
SALES
Net revenue for the nine months ended June 30, 2012 decreased $1,511,000 to $5,526,000 as compared to $7,037,000 for the nine months ended June 30, 2011. The reduction was due to a large sale to an aerospace company in the nine months ended June 30, 2011, which was not repeated in the nine months ended June 30, 2012, and lower sales at TransTech.
COST OF SALES
Cost of sales for the nine months ended June 30, 2012 decreased $1,342,000 to $4,513,000 as compared to $5,855,000 for the nine months ended June 30, 2011. The reduction was due to a large sale to an aerospace company in the nine months ended June 30, 2011, which was not repeated in the six months ended June 30, 2012, and lower sales at TransTech.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSE
Selling, general and administrative expenses for the nine months ended June 30, 2012 increased $28,000 to $2,754,000 as compared to $2,726,000 for the nine months ended June 30, 2011. We recorded $195,000 in expenses related to the SPP transactions during the nine months ended June 30, 2012.
During the nine months ended June 30, 2012, we recorded non-cash expenses of $742,000 and other business development and investor relation expenditures to expand the business.
The selling, general and administrative expenses consisted primarily of research and development expenses, employee and independent contractor expenses, overhead, equipment and depreciation, amortization of identifiable intangible assets and intellectual property, professional and consulting fees, investor relation, legal, patent, stock option and other general and administrative costs.
OTHER INCOME/EXPENSE
Other expense for the nine months ended June 30, 2012 was $109,000 as compared to other expense of $88,000 for the nine months ended June 30, 2011. The expenses for the nine months ended June 30, 2012 included $129,000 for interest expense, offset by $20,000 in other income. The other expense for the nine months ended June 30, 2011 included interest expense of $149,000, offset by other income of $61,000
NET LOSS
Net loss for the nine months ended June 30, 2012 was $1,928,000 as compared to a net loss of $1,729,000 for the nine months ended June 30, 2011 for the reasons discussed above. The net loss included non-cash expenses of 742,000 and other business development and investor relation expenditures to expand the business.
LIQUIDITY AND CAPITAL RESOURCES
We had cash of $3.1 million, a net working capital deficit of approximately $2.6 million (which includes $1.65 million due to James Gingo) and total indebtedness of $2.5 million as of June 30, 2012.
We will need to obtain additional financing to implement our business plan and service our debt repayments (including $650,000 that was due to James Gingo on June 8, 2012 related to the acquisition of TransTech). There can be no assurance that we will be able to secure funding, or that if such funding is available, the terms or conditions would be acceptable to us. If the Company is unable to obtain additional financing, we may need to restructure our operations, divest all or a portion of our business.
Our recent efforts to generate additional liquidity, including through sales of our common stock, are described in more detail in the financial statement notes set forth in this prospectus.
If we raise additional capital through borrowing or other debt financing, we will incur substantial interest expense. Sales of additional equity securities will dilute on a pro rata basis the percentage ownership of all holders of common stock. When we raise more equity capital in the future, it will result in substantial dilution to our current stockholders.
OPERATING ACTIVITIES
Net cash provided by operating activities for the nine months ended June 30, 2012 was $407,000. This amount was primarily related to a net loss of $1,928,000, offset by depreciation and amortization and other non-cash expenses of $742,000 and an increase in accrued expenses of $478,000 and deferred revenue of $916,000.
FINANCING ACTIVITIES
Net cash provided by financing activities for the nine months ended June 30, 2012 was $2,573,000. This amount was primarily related to proceeds from the sale of common stock of $2,627,000.
The Company’s contractual cash obligations as of June 30, 2012 are summarized in the table below:
| Contractual Cash Obligations | Total | Less Than 1 Year | 1-3 Years | 3-5 Years | Greater Than 5 Years |
|---|---|---|---|---|---|
| Operating leases | $291,380 | $57,012 | $114,024 | $120,344 | $0 |
| Capital lease obligations | 0 | 0 | 0 | 0 | 0 |
| Note payable | 2,513,131 | 2,507,491 | 5,640 | 0 | 0 |
| Capital expenditures | 325,000 | 75,000 | 100,000 | 75,000 | 75,000 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 |
| $3,129,511 | $2,639,503 | $219,664 | $195,344 | $75,000 |
Controls and procedures
As filed, 3,971 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
a) Evaluation of Disclosure Controls and Procedures
We have adopted and maintain disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act, is recorded, processed, summarized and reported within the time periods required under the SEC’s rules and forms and that the information is gathered and communicated to our management to allow for timely decisions regarding required disclosure.
As required by Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, our management conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2012. Our disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and our management necessarily was required to apply its judgment in evaluating and implementing our disclosure controls and procedures. Based upon the evaluation described above, our management concluded that they believe that our disclosure controls and procedures were not effective, as of September 30, 2011, in providing reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management to allow timely decisions regarding required disclosures, and is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Management identified the weaknesses discussed below.
Identified Material Weakness
A material weakness in our internal control over financial reporting is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement of the financial statements will not be prevented or detected. Management identified material weaknesses during its assessment of internal controls over financial reporting as of June 30, 2012.
While we have an audit committee, the financial expert is not independent and attended 50% of the committee meetings during 2011. The Company is currently reviewing the financial expert situation.
MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we assessed the effectiveness of our internal control over financial reporting as of the end of the period covered by this report based on the framework in “Internal Control—Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on that assessment, our principal executive officer and principal financial officer concluded that our internal control over financial reporting were not effective to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of our financial statements for external purposes in accordance with United States generally accepted accounting principles.
The effectiveness of our internal control over financial reporting as of June 30, 2012 has not been audited by Madsen Associates, CPA’s Inc., an independent registered public accounting firm.
CHANGES IN INTERNAL CONTROL
There has been no change in our internal control over financial reporting during the quarter ended June 30, 2012 that has materially affected or is likely to materially affect our internal control over financial reporting.
Risk factors
As filed, 12,492 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There are certain inherent risks which will have an effect on the Company’s development in the future and some of these risk factors are noted below but are not all encompassing since there may be others unknown to management at the present time which might have an impact in the future on the development of the Company.
WE WILL NEED ADDITIONAL FINANCING TO SUPPORT OUR TECHNOLOGY DEVELOPMENT AND ONGOING OPERATIONS.
We had cash of $3.1 million, a net working capital deficit of approximately $2.6 million (which includes $1.65 million due to James Gingo) and total indebtedness of $2.5 million as of June 30, 2012.
We will need to obtain additional financing to implement our business plan and service our debt repayments (including $650,000 that was due to James Gingo on June 8, 2012 related to the acquisition of TransTech). There can be no assurance that we will be able to secure funding, or that if such funding is available, the terms or conditions would be acceptable to us. If the Company is unable to obtain additional financing, we may need to restructure our operations, divest all or a portion of our business.
Our recent efforts to generate additional liquidity, including through sales of our common stock, are described in more detail in the financial statement notes set forth in this prospectus.
If we raise additional capital through borrowing or other debt financing, we will incur substantial interest expense. Sales of additional equity securities will dilute on a pro rata basis the percentage ownership of all holders of common stock. When we raise more equity capital in the future, it will result in substantial dilution to our current stockholders.
THE SALE OF A SIGNIFICANT NUMBER OF OUR SHARES OF COMMON STOCK COULD DEPRESS THE PRICE OF OUR COMMON STOCK.
Sales or issuances of a large number of shares of common stock in the public market (including pursuant to the equity line of credit transaction that we entered into with Ascendiant Capital Partners, LLC) or the perception that sales may occur could cause the market price of our common stock to decline. As of August 10, 2012, there were approximately 82.2 million shares of common stock issued and outstanding. On April 2, 2012, we registered 7,600,000 shares of common stock for resale. In 2011, the Company also registered for resale up to 15,340,361 shares of common stock. Therefore, the amount of shares registered for resale constitutes a significant percentage of the issued and outstanding shares of the Company, and the sale of all or a portion of these shares could have a negative effect on the market price of our common stock. Significant shares of common stock are held by our principal shareholders, other Company insiders and other large shareholders. As “affiliates” (as defined under Rule 144 of the Securities Act (“Rule 144”)) of the Company, our principal shareholders, other Company insiders and other large shareholders may only sell their shares of common stock in the public market pursuant to an effective registration statement or in compliance with Rule 144.
Some of the present shareholders have acquired shares at prices as low as $0.001 per share, whereas other shareholders have purchased their shares at prices ranging from $0.07 to $0.75 per share.
FUTURE ISSUANCE OF COMMON STOCK RELATED TO CONVERTIBLE NOTES PAYABLE AND RELATED WARRANTS MAY HAVE A DILUTING FACTOR ON EXISTING AND FUTURE SHAREHOLDERS.
On May 19, 2011, we entered into a Securities Purchase Agreement (“Agreement”) with Gemini Master Fund, Ltd. and Ascendiant Capital Partners, LLC (“Investors”) pursuant to which the Company issued $1.2 million in principal amount of 10% convertible debentures which are due September 30, 2012, together with 5-year warrants to purchase 2,400,000 shares of the Company’s common stock. The purchase price for the debentures was 83.3% of the face amount, resulting in the Company receiving $1.0 million, less legal fees, placement agent fees and expenses as set forth below.
The Company filed a registration statement on Form S-1, which was declared effective on August 29, 2011, to register 15,340,361 shares of its common stock, including (i) up to 5,400,000 shares of our common stock for Gemini issuable on conversion and the exercise of a warrant issued to Gemini and (ii) up to 1,992,000 shares of our common stock for Ascendiant issuable on conversion of debt and the exercise of a warrant issued to Ascendiant. From the effective date of the registration statement through June 30, 2012, 5,365,605 shares of the Company’s common stock have been issued to Gemini upon conversion of $225,000 of the convertible debentures and interest of $12,664 at an average of $0.044 per share.
The conversion of the convertible notes payable and the related warrants will likely result in a substantial dilution of the value of the common shares for all shareholders.
RISKS ASSOCIATED WITH EQUITY LINE OF CREDIT WITH ASCENDIANT
The Securities Purchase Agreement dated June 17, 2011 with Ascendiant will terminate if our common stock is not listed on one of several specified trading markets (which include the OTCBB and Pink Sheets, among others), if we file protection from our creditors, or if a Registration Statement on Form S-1 or S-3 is not effective.
If the price or the trading volume of our common stock does not reach certain levels, we will be unable to draw down all or substantially all of our $3,000,000 equity line of credit with Ascendiant.
The maximum draw down amount every 8 trading days under our equity line of credit facility is the lesser of $100,000 or 20% of the total trading volume of our common stock for the 10-trading-day period prior to the draw down multiplied by the volume-weighted average price of our common stock for such period. If our stock price and trading volume decline from current levels, we will not be able to draw down all $3,000,000 available under the equity line of credit.
If we are not able to draw down all $3,000,000 available under the equity line of credit or if the Securities Purchase Agreement is terminated, we may need to restructure our operations, divest all or a portion of our business, or file for bankruptcy.
As of August 10, 2012, the Company has issued 5,365,884 shares for $383,141, or $.071 per share, under the Securities Purchase Agreement with Ascendiant. The Company has registered a total of 10,285,714 shares of common stock for resale by Ascendiant. Additional shares may be issued under the Securities Purchase Agreement, which will have a further dilutive effect on the Company’s existing shareholders.
WE MAY ENGAGE IN ACQUISITIONS, MERGERS, STRATEGIC ALLIANCES, JOINT VENTURES AND DIVESTITURES THAT COULD RESULT IN FINANCIAL RESULTS THAT ARE DIFFERENT THAN EXPECTED.
In the normal course of business, we engage in discussions relating to possible acquisitions, equity investments, mergers, strategic alliances, joint ventures and divestitures. Such transactions are accompanied by a number of risks, including:
- Use of significant amounts of cash;
- Potentially dilutive issuances of equity securities on potentially unfavorable terms;
- Incurrence of debt on potentially unfavorable terms as well as impairment expenses related to goodwill and amortization expenses related to other intangible assets; and
- The possibility that we may pay too much cash or issue too many of our shares as the purchase price for an acquisition relative to the economic benefits that we ultimately derive from such acquisition.
The process of integrating any acquisition may create unforeseen operating difficulties and expenditures. The areas where we may face difficulties include:
- Diversion of management time, during the period of negotiation through closing and after closing, from its focus on operating the businesses to issues of integration;
- Decline in employee morale and retention issues resulting from changes in compensation, reporting relationships, future prospects or the direction of the business;
- The need to integrate each Company's accounting, management information, human resource and other administrative systems to permit effective management, and the lack of control if such integration is delayed or not implemented;
- The need to implement controls, procedures and policies appropriate for a public Company that may not have been in place in private companies, prior to acquisition;
- The need to incorporate acquired technology, content or rights into our products and any expenses related to such integration; and
- The need to successfully develop any acquired in-process technology to realize any value capitalized as intangible assets.
From time to time, we have also engaged in discussions with candidates regarding the potential acquisitions of our product lines, technologies and businesses. If a divestiture such as this does occur, we cannot be certain that our business, operating results and financial condition will not be materially and adversely affected. A successful divestiture depends on various factors, including our ability to:
- Effectively transfer liabilities, contracts, facilities and employees to any purchaser;
- Identify and separate the intellectual property to be divested from the intellectual property that we wish to retain;
- Reduce fixed costs previously associated with the divested assets or business; and
- Collect the proceeds from any divestitures.
In addition, if customers of the divested business do not receive the same level of service from the new owners, this may adversely affect our other businesses to the extent that these customers also purchase other products offered by us. All of these efforts require varying levels of management resources, which may divert our attention from other business operations.
If we do not realize the expected benefits or synergies of any divestiture transaction, our consolidated financial position, results of operations, cash flows and stock price could be negatively impacted.
WE MAY INCUR LOSSES IN THE FUTURE.
We have experienced net losses since inception. There can be no assurance that we will achieve or maintain profitability.
THE MARKET PRICE OF OUR COMMON STOCK HAS BEEN AND MAY CONTINUE TO BE VOLATILE.
The market price of our common stock has been and is likely in the future to be volatile. Our common stock price may fluctuate in response to factors such as:
- Announcements by us regarding liquidity, significant acquisitions, equity investments and divestitures, strategic relationships, addition or loss of significant customers and contracts, capital expenditure commitments, loan, note payable and agreement defaults, loss of our subsidiaries and impairment of assets;
- Issuance of convertible or equity securities for general or merger and acquisition purposes;
- Issuance or repayment of debt, accounts payable or convertible debt for general or merger and acquisition purposes;
- Sale of a significant number of shares of our common stock by shareholders;
- General market and economic conditions;
- Quarterly variations in our operating results;
- Investor relation activities;
- Announcements of technological innovations;
- New product introductions by us or our competitors;
- Competitive activities; and
- Additions or departures of key personnel.
These broad market and industry factors may have a material adverse effect on the market price of our common stock, regardless of our actual operating performance. These factors could have a material adverse effect on our business, financial condition and results of operations.
FUTURE ISSUANCE OF STOCK OPTIONS, WARRANTS AND/OR RIGHTS MAY HAVE A DILUTING FACTOR ON EXISTING AND FUTURE SHAREHOLDERS.
The grant and exercise of stock options, warrants or rights to be issued in the future will likely result in a dilution of the value of our common shares for all shareholders. We have established a Combined Incentive and Non-Qualified Stock Option Plan and may in the future issue further stock options to officers, directors and consultants, which will dilute the interest of the existing and future shareholders. Moreover, we may seek authorization to increase the number of its authorized shares and sell additional securities and/or rights to purchase such securities at any time in the future. Dilution of the value of the common shares will likely result from such sales, which in turn could adversely affect the market price of our common stock.
Source: SEC EDGAR, the filing index for accession 0001199835-12-000503. Last ingested by Listed: Nov 6, 2026, 12:33 ET. Listed shows no prices and gives no investment advice.